SCHEMBL7606950

SCHEMBL7606950

CCCC(C)CP(=O)(O)C(F)(F)c1ccc(F)c(F)c1F

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
PDE2A O00408 1/20 0.31
UBE2M P61081 2/20 0.30
DCUN1D1 Q96GG9 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5057852 0.74 FOLH1 (0.48)
SCHEMBL8064187 0.74 PTPN1 (0.38) ALDH1A1
SCHEMBL3219002 0.72 PGK1 (0.48)
SCHEMBL28909637 0.65 CES2 (0.36)
SCHEMBL5051331 0.63 GGH (0.51)
SCHEMBL5052921 0.63 FOLH1 (0.34) ALDH1A1HPGD
SCHEMBL28909686 0.63 CES2 (0.35)
SCHEMBL779939 0.63 TAS1R3 (0.35) ALDH1A1
SCHEMBL878885 0.62 FDPS (0.54)
SCHEMBL206670 0.60 CES2 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002514184-A 2002-05-14 JP claimed
EP-1005348-A1 NAALADASE COMPOSITIONS AND METHODS FOR TREATING GLUTAMATE ABNORMALITY AND EFFECTING NEURONAL ACTIVITY IN ANIMALS GUILFORD PHARMACEUTICALS INC. (US) 2000-06-07 EP claimed
WO-1998013046-A1 NAALADASE COMPOSITIONS AND METHODS FOR TREATING GLUTAMATE ABNORMALITY AND EFFECTING NEURONAL ACTIVITY IN ANIMALS GUILFORD PHARMACEUTICALS INC. (US) 1998-04-02 WO claimed